These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 30067117)

  • 1. Lessons learned from lung and liver in-vivo gene therapy: implications for the future.
    van Haasteren J; Hyde SC; Gill DR
    Expert Opin Biol Ther; 2018 Sep; 18(9):959-972. PubMed ID: 30067117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors.
    Fraefel C; Jacoby DR; Lage C; Hilderbrand H; Chou JY; Alt FW; Breakefield XO; Majzoub JA
    Mol Med; 1997 Dec; 3(12):813-25. PubMed ID: 9440115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral-mediated gene transfer for cancer treatment.
    Wilson DR
    Curr Pharm Biotechnol; 2002 Jun; 3(2):151-64. PubMed ID: 12022258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress and prospects: prospects of repeated pulmonary administration of viral vectors.
    Sinn PL; Burnight ER; McCray PB
    Gene Ther; 2009 Sep; 16(9):1059-65. PubMed ID: 19641533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small But Increasingly Mighty: Latest Advances in AAV Vector Research, Design, and Evolution.
    Grimm D; Büning H
    Hum Gene Ther; 2017 Nov; 28(11):1075-1086. PubMed ID: 28835125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy in cystic fibrosis.
    Flotte TR; Laube BL
    Chest; 2001 Sep; 120(3 Suppl):124S-131S. PubMed ID: 11555567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses to adenovirus and adeno-associated vectors used for gene therapy of brain diseases: the role of immunological synapses in understanding the cell biology of neuroimmune interactions.
    Lowenstein PR; Mandel RJ; Xiong WD; Kroeger K; Castro MG
    Curr Gene Ther; 2007 Oct; 7(5):347-60. PubMed ID: 17979681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Directions in Pulmonary Gene Therapy.
    Vu A; McCray PB
    Hum Gene Ther; 2020 Sep; 31(17-18):921-939. PubMed ID: 32814451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy.
    Grimm D; Kay MA
    Curr Gene Ther; 2003 Aug; 3(4):281-304. PubMed ID: 12871018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Status on Clinical Development of Adeno-Associated Virus-Mediated Liver-Directed Gene Therapy for Inborn Errors of Metabolism.
    Ginocchio VM; Ferla R; Auricchio A; Brunetti-Pierri N
    Hum Gene Ther; 2019 Oct; 30(10):1204-1210. PubMed ID: 31517544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral vectors for gene transfer: a review of their use in the treatment of human diseases.
    Walther W; Stein U
    Drugs; 2000 Aug; 60(2):249-71. PubMed ID: 10983732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human gene therapy: novel approaches to improve the current gene delivery systems.
    Cucchiarini M
    Discov Med; 2016 Jun; 21(118):495-506. PubMed ID: 27448786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AAV6 Vector Production and Purification for Muscle Gene Therapy.
    Halbert CL; Allen JM; Chamberlain JS
    Methods Mol Biol; 2018; 1687():257-266. PubMed ID: 29067669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of Virus Vector-Mediated Gene Therapy in China.
    Lin Q; Wang DG; Zhang ZQ; Liu DP
    Hum Gene Ther; 2018 Feb; 29(2):98-109. PubMed ID: 29284296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In the rat liver, Adenoviral gene transfer efficiency is comparable to AAV.
    Montenegro-Miranda PS; Pichard V; Aubert D; Ten Bloemendaal L; Duijst S; de Waart DR; Ferry N; Bosma PJ
    Gene Ther; 2014 Feb; 21(2):168-74. PubMed ID: 24285217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes.
    Halbert CL; Rutledge EA; Allen JM; Russell DW; Miller AD
    J Virol; 2000 Feb; 74(3):1524-32. PubMed ID: 10627564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AAV-Mediated Gene Delivery to the Liver: Overview of Current Technologies and Methods.
    Palaschak B; Herzog RW; Markusic DM
    Methods Mol Biol; 2019; 1950():333-360. PubMed ID: 30783984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating adenovirus-adeno-associated virus hybrid vectors devoid of all viral genes.
    Lieber A; Steinwaerder DS; Carlson CA; Kay MA
    J Virol; 1999 Nov; 73(11):9314-24. PubMed ID: 10516040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus vector design in gene therapy.
    Günzburg WH; Salmons B
    Mol Med Today; 1995 Dec; 1(9):410-7. PubMed ID: 9415189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors.
    Wang D; Zhang F; Gao G
    Cell; 2020 Apr; 181(1):136-150. PubMed ID: 32243786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.